CD45 antigens are protein tyrosine phosphatases. A possible link was evaluated between expression of CD45 antigens on human myeloid progenitor cells (MPC) (colony-forming unit-granulocyte/macrophage [CFU-GM], burst-forming unit-erythroid [BFU-E], and colony-forming unit-granulocyte/erythroid/macrophage/megakaryocyte [CFU-GEMM]) and regulation of MPC by colony-stimulating factors (CSF) (interleukin 3 [IL-3], GM-CSF, G-CSF, M-CSF, and erythropoietin [Epo]), a GM-CSF/IL-3 fusion protein, and mast cell growth factor (MGF; a c-kit ligand). Treatment of cells with antisense oligodeoxynucleotides (oligos) to exons 1 and 2, but not 4, 5, or 6, of the CD45 gene, or with monoclonal anti-CD45, significantly decreased CFU-GM colony formation stimulated with GM-CSF, IL-3, fusion protein, and GM-CSF + MGF, but not with G-CSF or M-CSF. It also decreased GM-CSF, IL-3, fusion protein, and MGF-enhanced Epo-dependent BFU-E and CFU-GEMM colony formation, but had little or no effect on BFU-E or CFU-GEMM colony formation stimulated by Epo alone. Similar results were obtained with unseparated or purified (greater than or equal to one of two cells being a MPC) bone marrow cells. Sorted populations of CD343+ HLA-DR+ marrow cells composed of 90% MPC were used to demonstrate capping of CD45 after crosslinking protocols. Also, a decreased percent of CD45+ cells and CD45 antigen density was noted after treatment of column-separated CD34+ cells with antisense oligos to exon 1 of the CD45 gene. These results demonstrate that CD45 cell surface antigens are linked to stimulation of early human MPC by IL-3, GM-CSF, a GM-CSF/IL-3 fusion protein, and MGF.
Skip Nav Destination
Article navigation
1 August 1991
Article|
August 01 1991
CD45 cell surface antigens are linked to stimulation of early human myeloid progenitor cells by interleukin 3 (IL-3), granulocyte/macrophage colony-stimulating factor (GM-CSF), a GM-CSF/IL-3 fusion protein, and mast cell growth factor (a c-kit ligand).
H E Broxmeyer,
H E Broxmeyer
Department of Medicine Hematology/Oncology, Indiana University School of Medicine, Indianapolis 46202.
Search for other works by this author on:
L Lu,
L Lu
Department of Medicine Hematology/Oncology, Indiana University School of Medicine, Indianapolis 46202.
Search for other works by this author on:
G Hangoc,
G Hangoc
Department of Medicine Hematology/Oncology, Indiana University School of Medicine, Indianapolis 46202.
Search for other works by this author on:
S Cooper,
S Cooper
Department of Medicine Hematology/Oncology, Indiana University School of Medicine, Indianapolis 46202.
Search for other works by this author on:
P C Hendrie,
P C Hendrie
Department of Medicine Hematology/Oncology, Indiana University School of Medicine, Indianapolis 46202.
Search for other works by this author on:
J A Ledbetter,
J A Ledbetter
Department of Medicine Hematology/Oncology, Indiana University School of Medicine, Indianapolis 46202.
Search for other works by this author on:
M Xiao,
M Xiao
Department of Medicine Hematology/Oncology, Indiana University School of Medicine, Indianapolis 46202.
Search for other works by this author on:
D E Williams,
D E Williams
Department of Medicine Hematology/Oncology, Indiana University School of Medicine, Indianapolis 46202.
Search for other works by this author on:
F W Shen
F W Shen
Department of Medicine Hematology/Oncology, Indiana University School of Medicine, Indianapolis 46202.
Search for other works by this author on:
H E Broxmeyer
Department of Medicine Hematology/Oncology, Indiana University School of Medicine, Indianapolis 46202.
L Lu
Department of Medicine Hematology/Oncology, Indiana University School of Medicine, Indianapolis 46202.
G Hangoc
Department of Medicine Hematology/Oncology, Indiana University School of Medicine, Indianapolis 46202.
S Cooper
Department of Medicine Hematology/Oncology, Indiana University School of Medicine, Indianapolis 46202.
P C Hendrie
Department of Medicine Hematology/Oncology, Indiana University School of Medicine, Indianapolis 46202.
J A Ledbetter
Department of Medicine Hematology/Oncology, Indiana University School of Medicine, Indianapolis 46202.
M Xiao
Department of Medicine Hematology/Oncology, Indiana University School of Medicine, Indianapolis 46202.
D E Williams
Department of Medicine Hematology/Oncology, Indiana University School of Medicine, Indianapolis 46202.
F W Shen
Department of Medicine Hematology/Oncology, Indiana University School of Medicine, Indianapolis 46202.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1991) 174 (2): 447–458.
Citation
H E Broxmeyer, L Lu, G Hangoc, S Cooper, P C Hendrie, J A Ledbetter, M Xiao, D E Williams, F W Shen; CD45 cell surface antigens are linked to stimulation of early human myeloid progenitor cells by interleukin 3 (IL-3), granulocyte/macrophage colony-stimulating factor (GM-CSF), a GM-CSF/IL-3 fusion protein, and mast cell growth factor (a c-kit ligand).. J Exp Med 1 August 1991; 174 (2): 447–458. doi: https://doi.org/10.1084/jem.174.2.447
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement